# Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

> **NCT04220528** · PHASE2 · UNKNOWN · sponsor: **Fujian Cancer Hospital** · enrollment: 129 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Capecitabine/Tiggio

## Key facts

- **NCT ID:** NCT04220528
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 129 (ESTIMATED)
- **Last updated:** 2020-01-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04220528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04220528, "Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04220528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*